NCT00127153View on ClinicalTrials.gov

A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

PHASE3CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
HealthyPneumococcal Infections
Interventions
BIOLOGICAL

V110, pneumococcal vaccine polyvalent

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00127153 - A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) | Biotech Hunter | Biotech Hunter